CIMT is a well-known marker of subclinical atherosclerosis and its measurement is a noninvasive and inexpensive method of detecting subclinical atherosclerosis; it is in relationship to adiponectin, leptin and hsCRP. The gene discussed is ADIPOQ; the disease is atherosclerosis.